Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
05:27pm, Thursday, 28'th Apr 2022
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.
It's Not Too Late to Buy These Market-Beating Stocks
10:45am, Saturday, 23'rd Apr 2022
You haven't missed the boat just yet.
DexCom (DXCM) Stock: $560 Stock And Buy Rating
12:09am, Thursday, 21'st Apr 2022
The shares of DexCom, Inc. (NASDAQ: DXCM) have received a $560 price target from BTIG. These are the details.
Is DexCom (DXCM) a Solid Growth Stock? 3 Reasons to Think " Yes "
02:18pm, Tuesday, 19'th Apr 2022
DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.
According To Analysts, These 12 Fast-Rising Stocks Are On The Way Up
06:25pm, Thursday, 14'th Apr 2022
A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.
Why DexCom Surged 23.6% in March
12:16pm, Monday, 11'th Apr 2022
The diabetes management company has launched its latest product to be sold in the United Kingdom.
DexCom's (DXCM) Upcoming Launch to Boost Diabetes Management
11:18am, Tuesday, 05'th Apr 2022
DexCom's (DXCM) upcoming launch of Dexcom ONE CGM can help people in the U.K. to manage diabetes.
Customers Love These 3 Healthcare Companies
11:07am, Saturday, 02'nd Apr 2022
Net Promoter Scores can provide insights into customer satisfaction, and possibly lead to market-beating returns.
DexCom Announces 4-for-1 Stock Split. Here's What Investors Need to Know.
09:05am, Tuesday, 29'th Mar 2022
The medical device maker has already made impressive gains. A planned stock split may make shares even more attractive to investors.
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
12:03pm, Monday, 28'th Mar 2022
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
Is DexCom a Buy?
10:45am, Wednesday, 23'rd Mar 2022
There's a bevy of positive signs, but trouble is lurking on the horizon.
Stellar Sales Growth Trend Makes DexCom Stock A Wise Bet
07:30am, Thursday, 17'th Mar 2022
We believe that DexCom, best known for its continuous glucose monitoring systems, currently is an attractive pick over Amedisys stock (NASDAQ: AMED), a home health and hospice company with a similar r
DexCom (DXCM) to Boost Diabetes Management With New Approval
12:03pm, Tuesday, 15'th Mar 2022
DexCom's (DXCM) G7 CGM System receives CE Mark that can help people with diabetes in Europe, including pregnant women.
Dexcom Snags A New Diabetes Device Win After Covid-Related Delay
05:22pm, Monday, 14'th Mar 2022 Investor''s Business Daily
European officials approved Dexcom''s newest body-worn diabetes device on Monday, leading Dexcom stock to surge closer to its 50-day line.
Dexcom G7 Continuous Glucose Monitoring System Receives European CE Mark
01:33pm, Monday, 14'th Mar 2022 Benzinga
DexCom Inc''s (NASDAQ: DXCM ) Dexcom G7 Continuous Glucose Monitoring (CGM) System has secured European CE Mark for people with diabetes aged two years and older, including pregnant women. The Company adds that the Dexcom G7 all-in-one wearable warms with 30-minute sensor warm-up is faster than … Full story available on Benzinga.com
